Markets

Capacite Infraprojects will be reporting latest earnings on June 12.1 analyst estimates earnings of INR 3.00 per share as opposed to earnings of INR 0.600 per share in the same quarter of the previous year.Capacite Infraprojects is expected to report sales of INR 4.35 billion, an increase of 41.75% over the same period last year.Analysts estimate earnings of INR 1.16 per share for the current fiscal year. Last year, the company earned INR 13.40 per share.This story was written by Markets Insider’s RoboEddy, which automatically writes these stories based on data provided by our partners.

Bitcoin’s woes may be coming to an end. SOPA Images/Getty Images

Gainers Medley Management Inc. (NASDAQ:MDLY) rose 144.9% to $14.30 in pre-market trading after gaining 9% on Wednesday. Medley LLC recently received NYSE notice regarding delayed Form 10-Q filing. ZIVO Bioscience, Inc. (NASDAQ:ZIVO) rose 70% to $8.32 in pre-market trading after declining over 5% on Wednesday. Sphere 3D Corp. (NASDAQ:ANY) rose 41.5% to $2.83 in pre-market trading after jumping around 10% on Wednesday. Gryphon Digital Mining and Sphere 3D recently reported an agreement to purchase 250,000 Carbon Offset Credits. Oxford Industries, Inc. (NYSE:OXM) shares rose 13.6% to $111.47 in pre-market trading after the company reported upbeat results for its first quarter and issued strong Q2 forecast. The company also boosted its FY21 sales guidance. New Oriental Education & Technology Group Inc. (NYSE:EDU) rose 11.1% to $10.02 in pre-market trading after gaining over 5% on Wednesday. Credit Suisse recently downgraded the stock from Outperform to Neutral. The Original BARK Company (NYSE:BARK) rose 10% to $13.20 in pre-market trading after jumping over 9% on Wednesday. Solid Biosciences Inc. (NASDAQ:SLDB) rose 9.5% to $4.39 in pre-market trading. Solid Biosciences recently reported inducement grant to new Chief Regulatory Officer. Invesco Mortgage Capital Inc. (NYSE:IVR) rose 9.4% to $4.55 in pre-market trading. Invesco

Tesla CEO Elon Musk. REUTERS/Mike Blake

Gainers Aethlon Medical, Inc. (NASDAQ:AEMD) shares surged 388.2% to close at $10.79 on Wednesday in reaction to Zacks Article ‘AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An Infected Patient.’ The company recently announced the positive results from using its Hemopurifier in treating two critically ill COVID-19 patients, which is available under the FDA emergency use authorization (EUA). American Software, Inc. (NASDAQ:AMSWA) jumped 39.1% to settle at $28.27 after the company reported better-than-expected Q4 earnings. The GEO Group, Inc. (NYSE:GEO) surged 38.4% to close at $8.80 amid continued retail investor interest in high-short interest stocks. Washington Prime Group Inc. (NYSE:WPG) gained 34.6% to settle at $6.73. Clean Energy Fuels Corp. (NASDAQ:CLNE) surged 31.5% to close at $13.02 after declining over 4% on Tuesday. The9 Limited (NASDAQ:NCTY) jumped 30.7% to close at $17.11. SPI Energy Co., Ltd. (NASDAQ:SPI) gained 28.3% to settle at $7.99. SPI Energy’s subsidiary Solar4America recently launched a new cloud-based online monitoring and maintenance system, Apollo, for solar systems, energy storage, and smart energy management. Takung Art Co., Ltd. (NASDAQ:TKAT) surged 19.6% to close at $21.93. Atomera Incorporated (NASDAQ:ATOM) jumped 19.3% to settle at $27.93 after Craig-Hallum initiated coverage on the

SAN FRANCISCO, June 10, 2021 /PRNewswire/ — The global durable medical equipment rental market size is expected to reach USD 35.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.8% from 2021 to 2028. The growth is attributable to financial benefits offered by renting durable medical equipment (DME) as it aids in bridging the gap between capital availability and clinical needs. Moreover, before buying, renting DME helps in determining whether or not they are a suitable fit.Key suggestions from the report:The bathroom safety and medical furniture segment accounted for the largest revenue share of 56.4% in 2020 owing to growing technological innovations in such medical equipmentThe hospitals’ segment accounted for the largest revenue share of 59.2% in 2020 owing to huge patient footfall in comparison to laboratories and institutes coupled with growing need to keep up with technological advancementsNorth America contributed for the largest revenue share of 32.5% owing to the presence of dominant market players, high healthcare expenditure, and high adoption rate for advanced medical technologiesRead 187 page research report with ToC on “Durable Medical Equipment Rental Market Size, Share & Trends Analysis Report By Application, By End-use

HELSINKI, June 10, 2021 /PRNewswire/ — Valmet has on June 9, 2021, entered into agreements to acquire EWK Umwelttechnik GmbH, a German company manufacturing and supplying air emission control systems and after-installation services, and ECP Group, a Finnish manufacturer and maintainer of air emission control systems. These acquisitions complement Valmet’s customer offering in environmental technologies and related services.  The values of the acquisitions will not be disclosed. The acquisitions are estimated to be completed in July 2021. After the acquisitions are completed, Valmet’s Environmental Systems offering covers technologies and services for wet and dry flue gas cleaning, flue gas desulfurization, NOx reduction and burner systems for energy and process industries, and marine scrubbers. The acquisition of EWK Umwelttechnik EWK Umwelttechnik’s offering of emission control technologies includes electrostatic precipitators, wet absorbers, catalytic and heat recovery systems, and wastewater purification products. The company serves multiple customer segments, including wood-based panelboard, glass, mineral wool, and steel industries.The net sales of EWK Umwelttechnik were approximately EUR 22 million in 2020. The company, founded in 1868, is based in Kaiserslautern, Germany, and employs approximately 50 employees. “This acquisition is an excellent strategic fit for Valmet and our technology and services offering enhancing our customers’

LONDON and RALEIGH, N.C., and SHANGHAI, June 10, 2021 /PRNewswire/ — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”) and Nuance Pharma Limited (“Nuance Pharma”), today announce that the companies have entered into an agreement granting Nuance Pharma, a Shanghai-based specialty pharmaceutical company, the rights to develop and commercialize ensifentrine in Greater China (mainland China, Taiwan, Hong Kong and Macau). Ensifentrine is an investigational, first-in-class, inhaled, dual inhibitor of the enzymes phosphodiesterase 3 and 4 (“PDE3” and “PDE4”). This dual inhibition enables it to combine both bronchodilator and anti-inflammatory effects in one compound. Verona Pharma is currently conducting a global Phase 3 program evaluating ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease (“COPD”), with sites in the US, Europe and South Korea.”We are extremely excited about the formation of this strategic partnership with Nuance Pharma to further the development and future commercialization of ensifentrine in Greater China,” said David Zaccardelli, Pharm. D., President and CEO of Verona Pharma. “Nuance Pharma’s highly talented leadership team has deep experience developing and commercializing respiratory products across China and we look forward to working with them to bring ensifentrine to this important market.””Ensifentrine is an ideal fit for Nuance Pharma’s portfolio, given our

(RTTNews) – NextNav, a provider of next generation GPS, and Spartacus Acquisition Corp. (TMTS, TMTSW, and TMTSU), a special purpose acquisition company, announced Thursday a definitive merger agreement, which will result in NextNav becoming a public company. Upon the deal closure, the combined company will be named NextNav Inc., and its common stock and warrants will be listed on the Nasdaq under the ticker symbol “NN” and “NNW”, respectively. NextNav expects gross proceeds of up to $408 million from the business combination to be used to fuel growth in its current businesses, continue to build NextNav’s next generation GPS platform, expand products one of which is already deployed in 4,400 cities, and to expand its land-based radio positioning and timing network. NextNav’s platform serves a $100 billion global total addressable market in public safety, e911, mass market consumer apps, eVTOLs, UAVs and autonomous vehicles, IoT and critical infrastructure, and many other sectors. Beyond its technology and intellectual property, NextNav owns a one-of-a-kind portfolio of nationwide spectrum licenses for 2.4 billion MHz-PoPs of 900 MHz spectrum. NextNav will continue to be led by Ganesh Pattabiraman, Co-Founder, CEO and President of NextNav. Gary Parsons, Chairman of NextNav’s Board of Directors for

BOSTON, June 10, 2021 /PRNewswire/ — Global financial wealth reached an all-time high of $250 trillion in 2020 as household savings rose and markets showed unexpected resilience in the face of the protracted COVID-19 pandemic, according to a new report by Boston Consulting Group (BCG).The report, titled Global Wealth 2021: When Clients Take the Lead, reveals that despite the pandemic’s enduring financial impact, global prosperity and wealth grew significantly throughout the crisis and are likely to continue to expand significantly over the next five years, in line with the emerging economic recovery.According to the report, North America, Asia (excluding Japan), and Western Europe will be the leading generators of financial wealth globally, accounting for 87% of new financial wealth growth worldwide between now and 2025. Many wealth management clients in 2020 embraced alternative investments in their quest for higher returns, shifting away from low-yield debt securities. As part of this trend, real assets, led primarily by real estate ownership, reached an all-time high of $235 trillion. Nevertheless, Asia, which has the largest concentration of wealth in real assets ($84 trillion, 64% of the regional total) will see financial asset growth exceed real asset growth (7.9% versus 6.7%) in coming years. In